Group One Trading
IRD

Group One Trading’s Opus Genetics IRD Stock Holding History

Group One Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$6.02K – 8120
2023
Q4 		$6.02K Sell
2,000
-11,000
-85% -$32.5K ﹤0.01% 6440
2023
Q3 		$43.5K Buy
+13,000
New +$52.2K ﹤0.01% 5230
2022
Q3 		– Sell
-300
Closed -$1K – 8384
2022
Q2 		$1K Hold
300
– – ﹤0.01% 7650
2022
Q1 		$1K Sell
300
-4,700
-94% -$16.1K ﹤0.01% 7898
2021
Q4 		$19K Sell
5,000
-20,400
-80% -$81.8K ﹤0.01% 7016
2021
Q3 		$131K Buy
25,400
+23,200
+1,055% +$107K ﹤0.01% 5630
2021
Q2 		$12K Buy
+2,200
New +$10.9K ﹤0.01% 7464

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Group One Trading's IRD Position: Q2 2026 in Review

Group One Trading sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 10,594 shares — an estimated $49.4K sold.

Group One Trading first reported a position in IRD in Q3 2017 and held it in 12 quarters. The position peaked at $163K in Q3 2021. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Group One Trading reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 10,594 Opus Genetics shares in Q2 2026, an estimated $49.4K.
  • Group One Trading first reported a position in Opus Genetics in Q3 2017 and held it in 12 quarters.
  • Group One Trading's Opus Genetics position peaked at $163K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.